Japanese Classification of Esophageal Cancer, 11th Edition: part II and III.
Japanese Classification of Esophageal Cancer, 11th Edition: part II and III.
复制标题
日本食管癌的分类，第11版：第二部分和III。
DOI：
10.1007/s10388-016-0556-2
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Japan Esophageal Society
中科院分区：
文献类型：
--
作者：
Japan Esophageal Society
1.Subjects............................................................................................................................................................................61 1.1.肿瘤lesions....................................................................................................................的分类.61 1.1.1.可测量的lesions.....................................................................................................................61 1.1.2.不可测量的lesions...................................................................................................................61 1.1.3.目标lesions......................................................................................................................61 1.1.4.非目标lesions....................................................................................................................61 2.响应evaluation.................................................................................................................的方法...61 3.目标lesions...............................................................................................................的响应评估标准61 3.1.完整响应(CR)....................................................................................................................62 3.2.部分响应(PR).....................................................................................................................62 3.3.进展性疾病(PD)....................................................................................................................62 3.4.稳定型疾病(SD)....................................................................................................................62 4.非目标lesion.......................................................................................................的反应评价标准62 4.1.完整响应(CR)....................................................................................................................62 4.2.反应不完全/病情稳定的(IR/SD)............................................................................................................62 4.3.进展性疾病(PD)....................................................................................................................62 5.使用endoscopy................................................................................对原发病变的反应评估标准62 5.1.原发灶完全缓解(原发灶CR)....................................................................................62 5.2.原发病变反应不全/病情稳定(原发病变IR/SD).....................................................63 5.3.原发皮损进行性疾病(原发皮损PD)...................................................................................6.整体Response.....................................................................................................................7.最佳整体反响和confirmation..........................................................................................................................65 7.1。完整响应(CR)....................................................................................................................65 7.2.部分响应(PR).....................................................................................................................65 7.3.稳定型疾病(SD)....................................................................................................................65 7.4.进展性疾病(PD)....................................................................................................................65
1. Subjects............................................................................................................................................................................ 61 1.1. Classification of tumor lesions................................................................................................................................. 61 1.1. 1. Measurable lesions......................................................................................................................................... 61 1.1. 2. Non-measurable lesions................................................................................................................................. 61 1.1. 3. Target lesions................................................................................................................................................. 61 1.1. 4. Non-target lesions.......................................................................................................................................... 61 2. Methods for response evaluation.................................................................................................................................... 61 3. Response evaluation criteria for target lesions............................................................................................................... 61 3.1. Complete response (CR).......................................................................................................................................... 62 3.2. Partial response (PR)................................................................................................................................................ 62 3.3. Progressive disease (PD).......................................................................................................................................... 62 3.4. Stable disease (SD)................................................................................................................................................... 62 4. Response evaluation criteria for non-target lesion....................................................................................................... 62 4.1. Complete response (CR).......................................................................................................................................... 62 4.2. Incomplete response/stable disease (IR/SD)............................................................................................................ 62 4.3. Progressive disease (PD).......................................................................................................................................... 62 5. Response evaluation criteria for primary lesion using endoscopy................................................................................ 62 5.1. Complete response of primary lesion (primary lesion CR).................................................................................... 62 5.2. Incomplete response/stable disease of primary lesion (primary lesion IR/SD)..................................................... 63 5.3. Progressive disease of primary lesion (primary lesion PD)................................................................................... 64 6. Overall Response............................................................................................................................................................. 64 7. Best overall response and confirmation.......................................................................................................................... 65 7.1. Complete response (CR).......................................................................................................................................... 65 7.2. Partial response (PR)................................................................................................................................................ 65 7.3. Stable disease (SD)................................................................................................................................................... 65 7.4. Progressive disease (PD).......................................................................................................................................... 65